1321 results about "Spot urine" patented technology

The ureter and urine bag comprises a urine bag body, a spiral pipe, a connecting pipe, a threaded connector pipe and a urine guiding pipe, the threaded connector pipe comprises a pipe body and an insertion pipe, internal threads with the thread pitch being 1.8-2.2 mm are machined on the inner wall of the pipe body, external threads matched with the internal threads are machined on the outer wall of the insertion pipe, and the spiral pipe is connected with the connecting pipe. Two groups of wing plates are symmetrically arranged on the outer wall of the cannula to provide rotating acting points, and a collecting assembly is integrated on the side wall of the urine bag and used for aseptically collecting urine samples. Traditional plug-pull type connection is replaced by a precise thread fit structure, a clear rotating force application point is provided for medical staff, operation is labor-saving and convenient, connector pollution is avoided, the urinary tract infection risk is effectively reduced, and the nursing comfort of a patient is improved.

The invention provides a diabetic nephropathy early warning method, system, equipment and medium, and relates to the technical field of medical data analysis and prediction.The method comprises the steps that multiple urine samples of a user are collected, target urine protein detection is conducted, and multiple urine protein concentrations are obtained; each urine protein concentration is combined with a normal urine protein concentration set to be input into an abnormal data recognition tree, the number of layers of multiple recognition nodes is obtained, and the detection confidence coefficient is obtained through calculation; configuring an abnormal proportion according to the detection confidence coefficient, inputting a plurality of urine protein concentration combination normal urine protein concentration sets into an abnormal data identification tree, deleting urine protein concentrations divided into abnormal data in the abnormal proportion before, and obtaining screened urine protein concentrations; according to the screened urine protein concentration, an auxiliary early warning coefficient is obtained through calculation, and early warning is carried out. The technical problem of low early warning accuracy of diabetic nephropathy in the prior art is solved.

The present invention belongs to the field of medical instruments. Disclosed is a pressure-relief urine bag, comprising: a bag internally provided with a urine storage cavity, wherein an input tube communicating the outside with the urine storage cavity is provided on the bag, and fluid can enter the urine storage cavity through the input tube, but the fluid in the urine storage cavity cannot be drained through the input tube; a warning structure comprising a pressure-sensing member and a vibration member, wherein the pressure-sensing member is electrically connected to the vibration member, the warning structure is connected to the bag, the pressure-sensing member is located in the urine storage cavity, and when the occupied space in the urine storage cavity reaches a set value, the fluid presses the pressure-sensing member and causes the vibration member to vibrate and produce sound; and an output tube, which is connected to the bag at one end, and comprises a manual urine drainage tube and an automatic urine drainage tube, wherein one end of the manual urine drainage tube is in communication with the urine storage cavity. The present invention can alert a patient and medical staff when the urine bag is about to be full of urine, and even if the patient and medical staff fail to notice and allow the urine bag to fill up, the urine in the bag can still be drained through the automatic urine drainage tube, thereby effectively preventing leakage or bursting caused by excessive pressure in the urine bag.

Doubly labeled water with enhanced protocol. One embodiment is a method including providing, to a user, a doubly labeled water (DLW) dose for the user to ingest, the DLW dose including deuterium and oxygen-18, wherein an amount of the deuterium is less than 0.12 grams per kilogram (g / kg) of body water of the user, and wherein an amount of the oxygen-18 is less than 0.18 g / kg of body water of the user. The method also includes receiving, from the user, a non-cooled shipment of urine samples collected in connection with ingestion of the DLW dose, wherein the urine samples remain uncooled after collection and during transit for a period of up to 24 days. The method further includes processing the urine samples with a liquid water isotope analyzer to determine one or more metabolic parameters of the user.

The invention relates to methods, devices, and software for distinguishing hemoglobin (Hb) from myoglobin (Mb) in urine samples using peroxidase-reactive test strips. A time-resolved video of the color change on the test pad is recorded, and hue values are extracted and analyzed over time. Diagnostic differentiation between Hb and Mb is achieved by evaluating the hue-time curve, in particular via endpoint hue values and the ratio of integrated hue values in distinct time intervals. The invention further comprises a standardized optical setup for recording, a software-based evaluation algorithm, and a refillable cartridge for in-situ urine analysis devices containing appropriate test fields. The invention enables combined testing with additional urine parameters and is suitable for medical and non-clinical applications such as sport and home diagnostics.

A urine management device includes a collection chamber hingedly coupled to a base. The base includes a proximal side and a distal side. The proximal side of the base is configured to contact a pelvic area of a user and the distal side faces the collection chamber. During application, the collection chamber can be folded out of the way, allowing a clinician full access to adhere the base to the pelvic area of the user. Once the base is securely adhered to the pelvic area of the user, the collection chamber can be folded back and coupled to the distal side of the base, creating a secure seal. The collection chamber is configured to (i) collect urine exiting an anatomy of the user and (ii) direct the urine in the collection chamber toward an outlet.

The invention relates to the technical field of medical health monitoring, and discloses a urine volume detection system based on a strain gauge type sensor, which comprises a urine collection container, a strain gauge type sensor, an electromagnetic valve, a main controller and an infrared human body sensor, the upper port of the urine collecting container is used for receiving urine, and the lower port of the urine collecting container is connected with the strain gauge type sensor; the strain gauge type sensor is used for detecting the weight change of the urine collection container, the urine volume detection system based on the strain gauge type sensor and the intelligent closestool overcome the defect that a traditional closestool cannot measure and record the urine volume, convenience is brought to patients who do not want to use a urinal or a pedestal pan and old people with poor eyesight, and the intelligent closestool is convenient to use. A user can know the urine volume when using the closestool or pouring urine into the urinal into the closestool, use is convenient and sanitary, accurate urine volume data helps a doctor to formulate a more accurate medication scheme for a patient, and the patient is prevented from seeing a doctor repeatedly and the health risk caused by medicine problems.

Disclosed herein is a urine collection bag, system, and methods directed to automated measurement of a quantity of urine. The urine collection system can include the urine collection bag, a catheter, and flexible drainage tubing. The urine collection bag can include a collection area, force sensors, and circuitry configured to determine the volume of urine in the collection area based on pressure or weight measured by the force sensors, and the specific gravity of the urine. The catheter may include a small female external catheter (FEC) with an opening on a top side, a wicking catheter with a wicking area on a top side, a finger-mountable catheter, or a male external catheter (MEC). The tubing may be secured to a patient's leg with a stabilization device or a fabric strap. The catheter can remain on a patient while the patient stands or walks.

The invention relates to a urine specific protein detection sample quality screening system and screening method. The screening method comprises the following steps: firstly, creating a urine specific protein quality model; then collecting an image of a to-be-detected sample; and finally, analyzing and evaluating the sample to be detected according to the sample quality model and the image of the sample to be detected, and converting urine colors (such as light yellow, deep yellow, hematuria and the like) into quantifiable numerical values by collecting the image of the sample (urine). Compared with traditional naked eye observation, judgment deviation caused by subjective factors such as experience and ambient light of detection personnel is avoided, and the detection result is more objective and repeatable; according to the method, the sample image is converted into quantifiable numerical values so as to carry out numerical analysis on the detection data of the color, clarity and turbidity of the sample, hematuria and urine with high turbidity in the sample are automatically screened out, manual operation steps are reduced, the detection efficiency is improved, and the method is particularly suitable for clinical or large-scale screening scenes.

The invention relates to a method for removing a chemical substance from human excreta, such as faeces and urine, comprising the following steps of: providing a toilet for a person from whose excreta the chemical substance must be removed; releasably connecting a filtering device to the toilet, wherein the filtering device comprises at least one removable cartridge with a filter; transporting the excreta by means of a transport screw from the toilet toward the filter in the cartridge, wherein pressure is exerted on the excreta by means of a plunger; filtering the chemical substance out of the excreta in situ using the filtering device; periodically replacing the at least one cartridge; and processing the replaced cartridge. The invention also relates to a filtering device for application in this method, and a cartridge for use in such a filtering device.

The present application provides a urine processing method and a urine testing system. The method comprises processing urine to obtain urinary sediment and supernatant, performing crystallization processing on the supernatant and making analysis to obtain supernatant-related parameters, and making comprehensive analysis through combination of the supernatant-related parameters with urinary sediment-related parameters and urine dry chemistry-related parameters. The system comprises a urine processing module configured to process urine to obtain urinary sediment and supernatant, and a supernatant analysis module configured to perform crystallization processing on the supernatant and make analysis to obtain supernatant-related parameters, and to make comprehensive analysis through combination of the supernatant-related parameters with the urinary sediment-related parameters and the urine dry chemistry-related parameters.

The invention discloses a high-precision real-time urodynamic monitoring method and system, and belongs to the technical field of medical monitoring. A urine flow sensor is arranged at the downstream of a catheterization assembly to collect urine flow and generate an electric signal; the electric signals are transmitted to a micro-control unit for digital processing, and the instantaneous flow velocity of urine, the accumulated urine volume per hour and the total urine volume of 24 hours are calculated in real time through an integral flow velocity algorithm; a calculation result is output to a local display screen, and real-time data viewing and historical curve graph and statistical report display are supported; meanwhile, the urine volume data are packaged according to timestamps and patient identifications and uploaded to a hospital nursing information system through a standardized interface protocol; if it is detected that the urine volume is abnormally lower than a set threshold value or is completely in a urine-free state, the system automatically triggers an alarm and pushes the alarm to the nursing terminal; by means of the method, automation, informatization and intelligentization of urine volume monitoring can be achieved, and the method is suitable for continuous nursing requirements of ICU and other critical areas.

The invention discloses a culture method of high-activity human urine-derived stem cells, which relates to the technical field of biological medicine, and is technically characterized by comprising the following steps: collecting urine samples of pregnant and lying-in women, coating a culture plate with gelatin, inducing adherence, performing passage amplification, performing immunofluorescence identification, performing function detection and other optimized conditions, and separating and culturing the stem cells. Compared with urine-derived stem cells of normal adults, the stem cells derived from pregnant women have stronger activity, higher dryness and faster multiplication capacity. The invention provides a novel and superior cell source for tissue engineering and regenerative medicine.

The application provides a stone composition multi-modal prediction method and system based on urine analysis, and belongs to the technical field of medical detection and artificial intelligence. The method comprises the following steps: acquiring a multi-modal data set of urine of a stone patient; identifying a crystal type; generating a metabolic feature matrix; extracting features from the crystal type identification result to generate a crystal feature vector; performing standardization processing on the metabolic feature matrix and the crystal feature vector to obtain a fusion feature matrix; inputting the fusion feature matrix into an extreme gradient boosting tree model to output an initial probability of a stone composition; inputting the initial probability of the stone composition into a bidirectional long short-term memory network model to output a probability distribution of the stone composition, and completing stone composition prediction. The application breaks through the limitations of traditional technologies in terms of accuracy, efficiency, cost, applicability and the like, and provides a feasible solution for early diagnosis, personalized treatment and popularization of primary medical treatment of urinary stones.

The invention provides a stone component multi-modal prediction method and system based on urine analysis, and belongs to the technical field of medical detection and artificial intelligence crossing. The method comprises the following steps: acquiring a multi-modal data set of urine of a stone patient; identifying the crystal type; generating a metabolic characteristic matrix; performing feature extraction on the crystal type identification result to generate a crystal feature vector; standardizing the metabolism characteristic matrix and the crystallization characteristic vector to obtain a fusion characteristic matrix; inputting the fusion feature matrix into an extreme gradient boosting tree model, and outputting the initial probability of the calculus component; and inputting the initial probability of the calculus component into the bidirectional long-short-term memory network model, and outputting probability distribution of the calculus component to complete calculus component prediction. The method breaks through the limitation of the traditional technology in the aspects of accuracy, efficiency, cost, applicability and the like, and provides a feasible solution for early diagnosis, personalized treatment and basic medical popularization of urinary calculi.

A urinary collection device includes an outer surface and a generally fluid-permeable core that communicates fluidically with an aspiration tube. The outer surface includes an obverse opening to allow urine to flow into the fluid-permeable core when the device is positioned supralabially. On the reverse may be an actuatable fastener configured to retain the device in a reverse-folded intralabial position. In this manner the device may be placed supralabially or intralabially for urine collection as appropriate. The core may include a first knit fabric layer and a second knit fabric layer joined by a plurality of fibers, the fibers being oriented generally to extend from an obverse to a reverse position to thereby result in flow channels through the core.

The utility model discloses a leakproof urine bag relates to disposable urine bag field, including urine bag and bag mouth, urine bag is formed by laminating first membrane layer and second membrane layer, water soluble membrane is provided in the urine bag, and together with urine bag bottom enclose a hollow sealed holding cavity, the holding cavity is provided with absorbent material, the urine bag is provided with the ring groove, the ring groove is provided with the water soluble membrane. A ring groove is formed by an interlayer space between a first film layer and a second film layer, a bridle is movably connected into the ring groove, one end of the bridle is fixed to the first film layer of the ring groove, the other end of the bridle penetrates out of a notch, the penetrating-out end of the bridle is pulled, the bridle is circumferentially wound around the urine bag in the horizontal direction, and the bag opening is closed. After urine is in contact with the water-soluble film, the water-soluble film is dissolved, the urine is absorbed to form solid waste after being in contact with the water-absorbing material, even if the urine bag is damaged, the urine cannot flow out, and the effects of protecting skin, keeping air fresh, reducing the workload of nurses and keeping the environment clean and sanitary when the urine bag is thrown away are achieved.

Device and methods for detection of kidney cancer using urine samples are disclosed herein. The device and methods enable isolation and quantification of kidney tumor cells in urine samples from a subject in need thereof.

The invention discloses an integrated urine collector, and belongs to the technical field of clinical examination and test equipment. The integrated urine collector is composed of a collecting cup, a one-way valve and a test tube, the one-way valve is arranged at the tail end of a liquid inlet tube of the collecting cup, a tube sleeve of the one-way valve is connected with the tail section of the liquid inlet tube of the collecting cup in a sleeved mode, and a valve block of the one-way valve is tightly attached to a liquid outlet of the liquid inlet tube of the collecting cup in a matched mode; the test tube is fixedly connected with the fixing sleeve of the collection cup in a buckling manner. The integrated urine collector is simple in structure, simple in manufacturing process, convenient to assemble and use, free of secondary pollution, good in sealing performance and safety, and capable of ensuring that quantitative and accurate middle-section urine can be obtained every time, so that the inspection quality and the working efficiency are greatly improved.

The invention provides a urine HCG full-automatic detection and urine routine combined detection system, which comprises a host shell, an interactive interface, a sample interface, a USB interface, a sampling and sample introduction module, a urine detection module, a urine detection module, a urine detection module and a urine routine detection module, the microfluidic and reagent module is used for automatically distributing and reacting urine samples; the multifunctional automatic detection module is used for performing optical detection and electrochemical detection and completing combined detection of HCG and urine routine; the data processing module is used for collecting original signals and carrying out data processing and calculation to obtain HCG concentration, urine routine multi-parameter results and a detection report; and the intelligent diagnosis support module is used for performing medical correlation analysis and medical record intelligent diagnosis. Through combined detection of HCG and urine routine, HCG and urine routine results can be obtained at the same time, the detection efficiency is improved, and the detection accuracy and sensitivity are enhanced through optical detection and electrochemical detection processes.

The disclosed embodiments relate to system, method and apparatus for forming ML sessions so that an AI system can identify, track and diagnose a user through the user's bathroom sessions. As used herein, a session is a period of time during which a user is active in the toilet. The session may include certain inactivity if such inactivity lasts only for a predefined duration. In an exemplary embodiment, a system is configured to capture images of excreta and, using ML algorithms, classifies the toileting session using Digital Biomarkers (DBMs). The ability to create an excreta log to accurately deliver detailed information to doctors and healthcare providers can revolutionize healthcare by notifying when further urine or fecal screening is necessary. The disclosed embodiments of ML and image identification through AI requires no user behavior change and provides a link between medical records and specific excreta patterns.

A catheter insertable into a urethra for installation in a user's bladder and urethra, the catheter comprising: a urine conduit comprising a first urine inlet and a urine outlet; and an inlet protector extending outwardly from the urine conduit from a position between the first urine inlet and the urine outlet, where the inlet protector functions to protect the urine inlet by separating it from contact with the bladder wall and thus keeping it out of contact with tissue.

The invention relates to the technical field of biological detection, and discloses a reagent composition for detecting urothelial carcinoma, a kit and application. The composition provided by the invention is used for detecting the methylation state of a specific target sequence in a characteristic gene of the urinary tract epithelial cancer, and the detection sensitivity and specificity of the urinary tract epithelial cancer are at a relatively high level. The composition provided by the invention can be used for noninvasive urinary tract epithelium cancer screening, and when the composition is used for urinary tract epithelium cancer screening, compared with conventional urine cytology examination and iconography examination, the detection sensitivity is greatly improved, the early screening accuracy of urinary tract epithelium cancer is improved, and the misdiagnosis rate and the missed diagnosis rate are greatly reduced.

The invention discloses an engineered artificial vesicle and application of the engineered artificial vesicle in multiple in-situ detection of urine exosome miRNA, and belongs to the field of biosensors. The method comprises the following steps: constructing planar framework nucleic acid simultaneously modified with cholesterol and an aptamer through annealing reaction; a molecular beacon with a fluorophore is designed according to a target gene sequence, and the molecular beacon and a double-strand specific nuclease (DSN) system are jointly encapsulated in an artificial vesicle; the engineered artificial vesicles and a sample to be detected are incubated, the fluorescence modified molecular beacons can specifically recognize target genes, cyclic cutting and signal amplification are achieved under DSN mediation, and the broken molecular beacons release fluorescence signals; all fluorescence signals in the vesicles are collected through a fluorescence imaging technology, and a characteristic fluorescence spectrum of the to-be-detected sample is obtained. According to the present invention, the miRNA heterogeneity analysis at the single vesicle level and the precise multi-target detection of bladder cancer and other diseases can be achieved, and the problems of low throughput, target number limitation and the like of the existing vesicle in-situ detection are effectively overcome.

The invention relates to a urine metabolism combined marker for diagnosing bladder cancer and a screening method of the urine metabolism combined marker. The urine metabolism combined marker is prepared from 2-methyl furan, dimethyl disulfide, octylene and acetophenone. The method for screening the urine metabolism combined marker comprises the following steps: carrying out chromatographic separation and mass spectrometry detection on a urine sample on the basis of a headspace automatic sampler in combination with a chromatographic column and a photochemical ionization time-of-flight mass spectrometry, preprocessing mass spectrometry data, and extracting spectrum peak data of metabolites in urine; the urine metabolism combination marker for diagnosing bladder cancer is obtained through further statistical analysis. The screening method of the urine metabolism combined marker for diagnosing the bladder cancer has the advantages of non-invasiveness, high-throughput detection, simplicity in operation and accurate result, and has a wide application prospect.

The invention relates to the technical field of biomedical detection, and discloses a portable urine component detection system and method based on a fluorescence sensor array. The system comprises a fluorescence sensor array, different fluorescence probes are used for detecting different trace components in urine, and fluorescence color gradient changes are generated through a probe-target object reaction, so that bilirubin, glucose and albumin in the urine are detected. The detection system comprises a micro-fluidic chip which integrates a capillary driving channel and a colorimetric reaction area and is used for sample transmission and reaction area positioning; an ultraviolet excitation light source and a multi-angle optical sensor are arranged in the camera obscura type color acquisition module, and the camera obscura type color acquisition module eliminates ambient light interference and captures fluorescence chromaticity signals; and the intelligent data processing system is integrated with an intelligent analysis end of the smart phone, establishes a quantitative relationship between chromaticity parameters (RGB and hue saturation) and the concentration of a target object through a machine learning model, and outputs a detection result in combination with an ambient light correction algorithm.

A device and method for removing by suction urine voided by a patient. The device includes an impermealble bag, a wicking pad, a spacer, and an adhesive patch. The bag includes an internal chamber and an entryway through which the penis of the patient is inserted. The wicking pad has a first portion located within the chamber and a second portion located outside the bag in communication with the ambient atmosphere. The adhesive patch secures the device to the patient. The bag includes a port at which regulated suction is provided to carry urine from the patient through the first portion of the wicking pad and out the port. Ambient air flows into the second portion to facilitate the flow of urine therethrough and to aid in drying the wicking pad. The spacer is located outside the bag for enhancing air flow through the second portion.

The invention discloses a fluorescent probe for detecting spermine and spermidine in a water sample and urine as well as a preparation method and application of the fluorescent probe, and relates to the technical field of supramolecular fluorescent probes, and the fluorescent probe is formed by reacting 14-membered cucurbit urils (tQ [14]) and a compound (E)-1-(4-boron benzyl)-4-(4-hydroxyl styryl) quinoline-1-ammonium bromide according to a molar ratio of 1: 1. The novel fluorescent probe provided by the invention can specifically detect spermine and spermidine in a water sample and urine, and the preparation method of the fluorescent probe is simple and easy to implement; the method for detecting spermine and spermidine in a water sample and urine by using the fluorescent probe has the advantages of high sensitivity, high selectivity, low cost, simple sample treatment, convenient operation, rapid determination and the like.

An example urine suction device suitable for extracting urine from a urine collection device is disclosed. The suction device can include a motor, a pump driven by the motor, a conduit, and an acoustic silencer. The pump can extract urine from a urine collection device. The acoustic silencer can be in fluid communication with the pump and conduit. The acoustic silencer can attenuate or reduce one or more acoustic waves generated by the pump and / or the motor. One or more components or structures within the acoustic silencer can at least partially attenuate the acoustic waves as they propagate along a non-linear airflow path defined by the acoustic silencer.

The rejection monitoring device comprises a bottom cylinder and a monitoring assembly, the monitoring assembly comprises a liquid inlet pipe connected to the outer side of the bottom cylinder, a partition plate is arranged on the outer side of a middle line of a connector of the liquid inlet pipe and the bottom cylinder, a pair of guide plates is arranged at the bottom end of the partition plate, and liquid guide holes are vertically formed in the two guide plates; a motor is arranged on the inner bottom wall of the bottom cylinder, the output shaft end of the motor is coaxially connected with a tray, a plurality of pairs of analysis cylinders are uniformly arranged on the tray, and the bottom ends of the two liquid guide holes are respectively aligned with any pair of analysis cylinders in the vertical direction; the urine and blood states of a patient can be regularly detected through the arranged monitoring assembly, the operation difficulty of medical staff is reduced, meanwhile, the sampling time and the time difference for obtaining the detection result can be shortened, and then the monitoring effect of the monitoring assembly is improved; red blood cells and proteins or other biochemical indexes in urine of a patient can be detected through the detection agent filled in the analysis cylinder.